Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - 28/07/11
, Johannes M.P.J. Breur, MD, PhD b, Martine F. Raphaël, MD c, Marike Vos, MD, MSc a, Corstiaan C. Breugem, MD, PhD d, Suzanne G.M.A. Pasmans, MD, PhD a
Reprint requests: Marlies de Graaf, MD, Department of Pediatric Dermatology/Allergology, University Medical Center Utrecht G02.124, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.Abstract |
Background |
Infantile hemangioma (IH) is a frequently encountered tumor with a potentially complicated course. Recently, propranolol was discovered to be an effective treatment option.
Objective |
To describe the effects and side effects of propranolol treatment in 28 children with (complicated) IH.
Methods |
A protocol for treatment of IH with propranolol was designed and implemented. Propranolol was administered to 28 children (21 girls and 7 boys, mean age at onset of treatment: 8.8 months).
Results |
All 28 patients had a good response. In two patients, systemic corticosteroid therapy was tapered successfully after propranolol was initiated. Propranolol was also an effective treatment for hemangiomas in 4 patients older than 1 year of age. Side effects that needed intervention and/or close monitoring were not dose dependent and included symptomatic hypoglycemia (n = 2; 1 patient also taking prednisone), hypotension (n = 16, of which 1 is symptomatic), and bronchial hyperreactivity (n = 3). Restless sleep (n = 8), constipation (n = 3) and cold extremities (n = 3) were observed.
Limitations |
Clinical studies are necessary to evaluate the incidence of side effects of propranolol treatment of IH.
Conclusions |
Propranolol appears to be an effective treatment option for IH even in the nonproliferative phase and after the first year of life. Potentially harmful adverse effects include hypoglycemia, bronchospasm, and hypotension.
Le texte complet de cet article est disponible en PDF.Key words : guideline, hemangioma, hypoglycemia, infant, propranolol, side effects, treatment
Abbreviations used : ECG, PHACE (syndrome), PELVIS (syndrome)
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 65 - N° 2
P. 320-327 - août 2011 Retour au numéro
Article précédent
- Poikilodermatous mycosis fungoides: A study of its clinicopathological, immunophenotypic, and prognostic features
- Rachel A. Abbott, Debjani Sahni, Alistair Robson, Nita Agar, Sean Whittaker, Julia J. Scarisbrick
- Simple ultraviolet and high-performance liquid chromatography methods for the evaluation of sunscreen efficacy
- Khin Lay Maw, Julianne Caton-Williams, Jozef Salon, Zhen Huang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?